别名 Angioblastoma、Capillary Hemangioblastoma、HEMANGIOBLASTOMA + [13] |
简介 A benign tumor of the nervous system that may occur sporadically or in association with VON HIPPEL-LINDAU DISEASE. It accounts for approximately 2% of intracranial tumors, arising most frequently in the cerebellar hemispheres and vermis. Histologically, the tumors are composed of multiple capillary and sinusoidal channels lined with endothelial cells and clusters of lipid-laden pseudoxanthoma cells. Usually solitary, these tumors can be multiple and may also occur in the brain stem, spinal cord, retina, and supratentorial compartment. Cerebellar hemangioblastomas usually present in the third decade with INTRACRANIAL HYPERTENSION, and ataxia. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2071-2) |
靶点 |
作用机制 HIF-2α抑制剂 |
最高研发阶段批准上市 |
首次获批国家/地区 美国 |
首次获批日期2021-08-13 |
开始日期2023-03-28 |
申办/合作机构 |
开始日期2023-03-03 |
申办/合作机构- |
开始日期2023-01-16 |